Manufacturing processes of plasma-derived products remove prions

被引：0
|
作者：
Groener, A. [1 ]
Schaefer, W. [1 ]
机构：
[1] CSL Behring, Virol, Marburg, Germany
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-MO-557
引用
收藏
页码：508 / 508
页数：1
相关论文
共 50 条
  • [31] SAFETY ASPECTS IN THE MANUFACTURING OF PLASMA-DERIVED COAGULATION-FACTOR CONCENTRATES
    BURNOUF, T
    BIOLOGICALS, 1992, 20 (02) : 91 - 100
  • [32] Safety Issues of Plasma-Derived Products for Treatment of Inherited Bleeding Disorders
    Farrugia, Albert
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2016, 42 (05): : 583 - 588
  • [33] West Nile virus neutralization by US plasma-derived immunoglobulin products
    Planitzer, Christina B.
    Modrof, Jens
    Kreil, Thomas R.
    JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (03): : 435 - 440
  • [34] Parvovirus B19 Is Inactivated by Pasteurization, a Dedicated Virus Inactivation Step in the Manufacturing Process of Plasma-Derived Products
    Groener, Albrecht
    Nowak, Thomas
    Schaefer, Wolfram
    BLOOD, 2009, 114 (22) : 1224 - 1224
  • [35] HUMAN PLASMA FRACTIONATION AND THE IMPACT OF NEW TECHNOLOGIES ON THE USE AND QUALITY OF PLASMA-DERIVED PRODUCTS
    BRODNIEWICZPROBA, T
    BLOOD REVIEWS, 1991, 5 (04) : 245 - 257
  • [36] Trends in Plasma Toll Fractionation for Self Sufficiency of Plasma-Derived Medicinal Products in Italy
    De Angelis, Vincenzo
    Breda, Antonio
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2019, 46 (04) : 232 - 238
  • [37] A probabilistic model for analyzing viral risks of plasma-derived medicinal products
    Janssen, Mart P.
    Over, Jan
    van der Poel, Cees L.
    Cuijpers, H. Theo M.
    van Hout, Ben A.
    TRANSFUSION, 2008, 48 (01) : 153 - 162
  • [38] Sustainability of a public system for plasma collection, contract fractionation and plasma-derived medicinal product manufacturing
    Grazzini, Giuliano
    Ceccarelli, Anna
    Calteri, Deanna
    Catalano, Liviana
    Calizzani, Gabriele
    Cicchetti, Americo
    BLOOD TRANSFUSION, 2013, 11 : S138 - S147
  • [39] Plasma-derived and recombinant FVIII
    Herzog, Roland W.
    BLOOD, 2009, 114 (04) : 753 - 754
  • [40] Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease
    Josephson, CD
    Abshire, TC
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2006, 19 (01) : 35 - 49
12345